Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Dividends declared (per SOCE filings): FY2021 0 · FY2022 0 · FY2023 0
Georgian pharmacy/pharmaceutical distribution company.
Subsidiary of Epa (90.0%)
| Ratio | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Margins | |||||||
| Gross Margin | 20.4% | 22.3% | 22.5% | 16.2% | 14.2% | 18.9% | 14.3% |
| EBITDA Margin | 13.6% | 6.3% | 5.7% | -2.3% | -5.9% | -4.1% | -18.9% |
| EBITDAR | 8,514 | 5,436 | 3,042 | 756 | 263 | 1,738 | -6,444 |
| EBITDAR Margin | 18.3% | 10.8% | 8.5% | 1.9% | 0.5% | 2.7% | -10.5% |
| EBIT Margin | 12.8% | 5.5% | 5.1% | -3.0% | -6.8% | -5.1% | -20.5% |
| Net Profit Margin | 3.1% | 4.6% | 2.9% | -8.2% | -3.0% | -4.8% | -18.2% |
| Operating Expense % of Sales | 6.9% | 16.0% | 16.8% | 18.5% | 20.1% | 23.0% | 33.2% |
| Returns | |||||||
| Return on Assets (ROA) | 10.2% | 13.6% | 4.0% | -9.5% | -4.2% | -6.4% | -16.9% |
| Return on Equity (ROE) | 89.7% | 59.1% | 48.7% | N/A | N/A | N/A | N/A |
| ROIC [EBIT / Invested Capital] | 129.8% | 37.8% | 15.5% | -8.7% | -38.7% | -29.6% | N/A |
| Leverage & debt balances | |||||||
| Debt-to-Assets | 24.0% | 22.2% | 45.3% | 48.0% | 33.6% | 35.9% | 33.7% |
| Debt-to-Equity | 2.12x | 0.97x | 5.53x | -13.06x | -4.45x | -2.92x | -1.30x |
| Debt-to-EBITDA | 0.55x | 1.19x | 5.76x | N/A | N/A | N/A | N/A |
| Equity-to-Assets | 11.3% | 22.9% | 8.2% | -3.7% | -7.6% | -12.3% | -26.0% |
| Net Debt | 2,961 | 3,405 | 9,710 | 15,368 | 12,510 | 17,243 | 15,871 |
| Cash & Equivalents | 485 | 343 | 2,169 | 1,346 | 353 | 338 | 6,565 |
| Total Debt | 3,446 | 3,748 | 11,879 | 16,714 | 12,864 | 17,581 | 22,435 |
| Liquidity & working capital | |||||||
| Current Ratio | 1.50x | 1.73x | 1.93x | 1.58x | 1.13x | 1.11x | 0.93x |
| Quick Ratio | 0.45x | 0.58x | 1.10x | 0.71x | 0.60x | 0.55x | 0.45x |
| Cash Ratio | 0.06x | 0.04x | 0.18x | 0.07x | 0.01x | 0.01x | 0.10x |
| Total Current Assets | 13,132 | 16,057 | 23,492 | 30,753 | 36,016 | 45,643 | 61,872 |
| Total Current Liabilities | 8,777 | 9,266 | 12,203 | 19,405 | 31,870 | 41,219 | 66,185 |
| Inventory | 9,219 | 10,669 | 10,105 | 16,888 | 16,941 | 22,917 | 32,223 |
| Trade Receivables | 1,243 | 1,220 | 6,306 | 8,105 | 6,959 | 8,414 | 8,756 |
| Trade Payables | 8,467 | 8,592 | 11,421 | 18,584 | 27,325 | 36,114 | 59,489 |
| Net Working Capital | 4,355 | 6,791 | 11,289 | 11,348 | 4,147 | 4,424 | -4,313 |
| Net Working Capital % of Revenue | 9.4% | 13.6% | 31.4% | 28.1% | 7.6% | 6.8% | -7.0% |
| Trade Working Capital | 1,995 | 3,298 | 4,990 | 6,409 | -3,425 | -4,783 | -18,510 |
| Trade Working Capital % of Revenue | 4.3% | 6.6% | 13.9% | 15.9% | -6.3% | -7.3% | -30.0% |
| Change in Trade Working Capital | N/A | 1,303 | 1,692 | 1,419 | -9,834 | -1,358 | -13,727 |
| Turnover & efficiency | |||||||
| Inventory Turnover | 4.02x | 3.65x | 2.76x | 2.00x | 2.77x | 2.32x | 1.64x |
| Days Inventory Outstanding (DIO) | 90.9 | 100.0 | 132.4 | 182.3 | 131.7 | 157.6 | 222.6 |
| Receivables Turnover | 37.44x | 41.07x | 5.70x | 4.98x | 7.86x | 7.78x | 7.04x |
| Days Sales Outstanding (DSO) | 9.7 | 8.9 | 64.0 | 73.3 | 46.4 | 46.9 | 51.8 |
| Payables Turnover | 4.37x | 4.53x | 2.44x | 1.82x | 1.72x | 1.47x | 0.89x |
| Days Payable Outstanding (DPO) | 83.5 | 80.5 | 149.6 | 200.6 | 212.5 | 248.3 | 411.0 |
| Cash Conversion Cycle | 17.2 days | 28.4 days | 46.8 days | 55.0 days | -34.3 days | -43.8 days | -136.6 days |
| Asset Turnover | 3.24x | 2.97x | 1.37x | 1.16x | 1.43x | 1.34x | 0.93x |
| Cash flow & dividends | |||||||
| Operating Cash Flow | 1,092 | -69 | -2,716 | -3,585 | 5,996 | -3,175 | 6,297 |
| Free Cash Flow (OCF − Capex proxy) | 1,092 | -311 | -2,830 | -4,879 | 4,578 | -4,724 | 3,079 |
| Cash Conversion (OCF / EBITDA) | 17.3% | -2.2% | -131.8% | N/A | N/A | N/A | N/A |
| Dividends Declared | 0 | 42 | 2,774 | 209 | 0 | 0 | 0 |
| Dividend Payout Ratio | 0.0% | 1.8% | 265.6% | N/A | N/A | N/A | N/A |
Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in GEL, thousands. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →